Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Cancer ; 88(2): 291-7, 2003 Jan 27.
Article in English | MEDLINE | ID: mdl-12610516

ABSTRACT

Intratumour heterogeneity in the uptake of blood-borne technetium-labelled human serum albumin ((99m)Tc-HSA) was studied in human melanoma xenografts in an attempt to identify transport barriers leading to inadequate and heterogeneous uptake of macromolecular therapeutic agents in tumours. The Bioscope imaging system, which can detect the distribution of (99m)Tc in 10-microm-thick tissue sections with a spatial resolution of just above 50 microm, was used to image the (99m)Tc-HSA uptake. Xenografted tumours of four human melanoma cell lines were included in the study. Significant intratumour heterogeneity in the uptake of (99m)Tc-HSA was detected. The heterogeneity had two distinctly different components, one random and one radial component. The uptake was lowest in the centre of the tumours and increased towards the tumour periphery. This radial heterogeneity was superimposed by a random heterogeneity, that is, spots with high uptake colocalised with spots with high vascular density and regions without significant uptake colocalised with necrotic regions. The magnitude of the heterogeneity did not change significantly with time after the administration of (99m)Tc-HSA. The tumours showed a random and a radial heterogeneity in blood perfusion similar to that in the uptake of (99m)Tc-HSA. The observations reported here suggest that the intratumour heterogeneity in the distribution of (99m)Tc-HSA was initiated primarily because of heterogeneity in the supply of (99m)Tc-HSA through the microvasculature, and that the presence of severe transport barriers in the tumour interstitium prevented significant equalisation of the initial heterogeneity with time. Consequently, strategies for improving the delivery of macromolecular therapeutic agents to tumours should focus on increasing the tumour blood perfusion to increase the total uptake and improving the diffusion conditions in the tumour interstitium to diminish the heterogeneity in the uptake.


Subject(s)
Melanoma, Experimental/metabolism , Neovascularization, Pathologic/pathology , Technetium Tc 99m Aggregated Albumin/pharmacokinetics , Animals , Biological Transport , Female , Humans , Macromolecular Substances , Melanoma, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Neovascularization, Pathologic/metabolism , Transplantation, Heterologous
2.
Int J Radiat Biol ; 78(2): 133-42, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11779363

ABSTRACT

PURPOSES: The alpha-emitting radionuclide 211At conjugated to the CD20 targeting chimeric monoclonal antibody rituximab was studied to: (a) Estimate radiation dose components to lymphoma and bone marrow (BM) cells exposed in vitro. (b) Calculate the mean absorbed radiation doses in various normal tissues of mice following intravenous injection. MATERIALS AND METHODS: B-lymphoma cells (RAEL) and normal human BM cells were incubated with increasing concentrations of the radioimmunoconjugate. Based on binding kinetics and on measured cellular and nuclear diameters, the radiation doses were calculated using microdosimetric methods. RESULTS: Targeting of 211At-rituximab to RAEL cells was extensive and stable compared with the binding to BM cells. The absorbed radiation doses from cell-bound activity at an initial activity concentration of 10 kBq ml(-1) were 0.645 and 0.021 Gy to RAEL and BM cells, respectively. In comparison, the contribution from unbound conjugate in the medium during 1h exposure was 0.042 and 0.043 Gy. The D(0) value for RAEL cells was 0.55 Gy, but only 0.34 Gy for BM cells, whereas corresponding D(0) values were 0.72 and 1.21 Gy after a single exposure to external 60Co gamma-rays. Mean absorbed doses of 1.31, 0.48 and 0.36 Gy for blood, lungs and heart were calculated in mice injected with 5.4kBq g(-1) of 211At-rituximab. CONCLUSION: Despite the higher inherent sensitivity of the BM cells to the alpha-irradiation, there was, related to the radioactivity concentrations of 211At-rituximab, several logs greater cell kill in RAEL cells, illustrating the tumour-specific nature of the targeting.


Subject(s)
Bone Marrow Cells/radiation effects , Gamma Rays , Lymphoma, Non-Hodgkin/radiotherapy , Animals , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Murine-Derived , Antigens, CD20/metabolism , Astatine/therapeutic use , Cell Nucleus/drug effects , Cell Nucleus/radiation effects , Cell Separation , Cells, Cultured , Dose-Response Relationship, Radiation , Flow Cytometry , Humans , Isotopes/therapeutic use , Kinetics , Mice , Mice, Inbred BALB C , Models, Statistical , Protein Binding , Radioimmunoassay , Radiometry , Rituximab , Time Factors , Tumor Cells, Cultured
3.
Phys Med Biol ; 46(4): 1149-61, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11324957

ABSTRACT

The purpose of the present work was to investigate how haematopoietic stem cell survival is affected by the differences in the dose distribution that arise from different radionuclides contained in bone-seeking radiopharmaceuticals. This was carried out in three steps: (a) calculations of representative dose distributions in individual bone marrow cavities that are irradiated by sources of 89Sr, 186Re, 117mSn or 153Sm, uniformly distributed on the bone surfaces; (b) assessment of the corresponding haematopoietic stem cell survival and (c) a comparison of these results with results obtained using the assumption of a uniform dose distribution. Two different idealized models of the geometry of trabecular bone were formulated, each consisting of an infinite array of identical elements. Monte Carlo simulations were used to generate dose-volume histograms that were used to assess haematopoietic stem cell survival with two different assumptions about spatial cell distributions. Compared with a homogeneous dose distribution, the estimated cell survival was markedly higher for 117mSn and 153Sm, and only slightly different for 89Sr and 186Re. The quantitative results differed between the two geometric models and the assumptions about spatial cell distribution, but the trends were the same. The results imply that it is necessary to include dose distributions for individual bone marrow cavities in considerations concerning bone marrow toxicity.


Subject(s)
Bone Neoplasms/radiotherapy , Monte Carlo Method , Age Factors , Cell Survival/radiation effects , Dose-Response Relationship, Radiation , Hematopoietic Stem Cells/radiation effects , Humans , Isotopes/therapeutic use , Models, Theoretical , Radioisotopes/therapeutic use , Radiotherapy Planning, Computer-Assisted/methods , Rhenium/therapeutic use , Samarium/therapeutic use , Strontium Radioisotopes/therapeutic use , Tin/therapeutic use
4.
Radiat Res ; 155(2): 288-96, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11175663

ABSTRACT

Intercellular variations in the level of antigen expression and in cellular and nuclear radii were taken into account in a model used to estimate cell survival for an in vitro experiment with antibodies containing alpha-particle emitters that target the cell surface. Using measured variations in these characteristics for cells of two human cancer cell lines, the model gave results for cell survival and the fundamental parameter of radiation sensitivity, z(0), that differ substantially from those obtained using only mean values. The cell survival may be underestimated by a factor of 100 if only mean values of these cellular parameters are used, and calculated values of z(0) may be overestimated by a factor of 2. Most of this effect stems from the variation in antigen expression. The magnitudes of the differences were found to be a function of the fractions of mean specific energy delivered by surrounding activity and by activity bound to the cells.


Subject(s)
Alpha Particles/therapeutic use , Antigens, Neoplasm/analysis , Cell Size , Radioimmunotherapy , Radiometry/methods , Radiotherapy Dosage , Antigens, CD20/analysis , Bone Neoplasms/immunology , Bone Neoplasms/pathology , Burkitt Lymphoma/immunology , Burkitt Lymphoma/pathology , Cell Nucleus/radiation effects , Cell Nucleus/ultrastructure , Cell Survival/radiation effects , Energy Transfer , Flow Cytometry , Humans , Models, Biological , Osteosarcoma/immunology , Osteosarcoma/pathology , Peptide Fragments/analysis , Thymopoietins/analysis , Tumor Cells, Cultured/immunology , Tumor Cells, Cultured/radiation effects , Tumor Cells, Cultured/ultrastructure
5.
Phys Med Biol ; 45(5): 1183-93, 2000 May.
Article in English | MEDLINE | ID: mdl-10843099

ABSTRACT

Two methods have been developed for the separation of contributions from two different nuclides in an autoradiography picture. Both approaches, a modified least squares (LS) and a maximum likelihood (ML) algorithm, are based on the position and energy information available from a digital detector. Tests and comparisons, using artificially as well as measured data, demonstrate that the ML approach performs slightly better, but is much more computationally demanding than the LS method.


Subject(s)
Autoradiography/methods , Algorithms , Animals , Autoradiography/statistics & numerical data , Biophysical Phenomena , Biophysics , Image Processing, Computer-Assisted/methods , Image Processing, Computer-Assisted/statistics & numerical data , Least-Squares Analysis , Likelihood Functions , Phosphorus Radioisotopes , Silicon , Sulfur Radioisotopes
SELECTION OF CITATIONS
SEARCH DETAIL
...